Qing Qing Yi
Directeur/Membre du Conseil chez BEIGENE, LTD.
Fortune : 201 895 $ au 30/04/2024
Profil
Mr. Qing Qing Yi is an Independent Non-Executive Director at BeiGene Ltd.
and a Partner at Hillhouse Capital Group Ltd.
He is on the Board of Directors at JD Health International, Inc., BeiGene Ltd.
and Hisun Pfizer Pharmaceuticals Co., Ltd.
Mr. Yi was previously employed as a Chairman by Genor Biopharma Holdings Ltd.
and a Non-Executive Director by Shanghai Junshi Biosciences Co., Ltd.
He also served on the board at Gossamer Bio, Inc. and Hibercell, Inc. He received his undergraduate degree from Shanghai Maritime University and an MBA from the University of Southern California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEIGENE LTD
0,00% | 19/04/2024 | 16 692 ( 0,00% ) | 201 895 $ | 30/04/2024 |
Postes actifs de Qing Qing Yi
| Sociétés | Poste | Début |
|---|---|---|
| BEIGENE, LTD. | Directeur/Membre du Conseil | 01/10/2014 |
| JD HEALTH INTERNATIONAL INC. | Directeur/Membre du Conseil | 21/08/2020 |
Hillhouse Capital Group Ltd.
 Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Corporate Officer/Principal | 01/01/2005 |
Hisun Pfizer Pharmaceuticals Co., Ltd.
 Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | 15/12/2017 |
Anciens postes connus de Qing Qing Yi
| Sociétés | Poste | Fin |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Président | 02/11/2021 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Directeur/Membre du Conseil | 29/06/2021 |
| GOSSAMER BIO, INC. | Directeur/Membre du Conseil | 19/12/2018 |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Qing Qing Yi
| Shanghai Maritime University | Undergraduate Degree |
| University of Southern California | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| JD HEALTH INTERNATIONAL INC. | Health Services |
| Entreprise privées | 3 |
|---|---|
Hillhouse Capital Group Ltd.
Hillhouse Capital Group Ltd. Investment ManagersFinance Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong. | Finance |
Hisun Pfizer Pharmaceuticals Co., Ltd.
Hisun Pfizer Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Hisun Pfizer Pharmaceuticals Co., Ltd. engages in the development, production, marketing, and sale of pharmaceutical products. It offers medicine in the form of tablets, hard capsules, and injection. The company was founded on September 6, 2012 and is headquartered in Hangzhou, China. | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |